Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Are Unique Regional Factors the Missing Link in India’s COVID-19-Associated Mucormycosis Crisis?
Jessy Skaria, Teny John, Shibu Varkey, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 21

Showing 21 citing articles:

The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)
Jon Salmanton‐García, Wing‐Yan Au, Martin Hoenigl, et al.
International Journal of Antimicrobial Agents (2023) Vol. 61, Iss. 3, pp. 106718-106718
Open Access | Times Cited: 52
Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India
Valliappan Muthu, Ritesh Agarwal, Shivaprakash M. Rudramurthy, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 1, pp. 8-19
Open Access | Times Cited: 47
COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic
Pankaj Chandley, Priyanka Subba, Soma Rohatgi
Vaccines (2022) Vol. 10, Iss. 8, pp. 1266-1266
Open Access | Times Cited: 22
What Is New in Fungal Infections?
Meredith G Parsons, Daniel J. Diekema
Modern Pathology (2023) Vol. 36, Iss. 6, pp. 100187-100187
Closed Access | Times Cited: 12
DectiSomes: C-type lectin receptor-targeted liposomes as pan-antifungal drugs
Richard B. Meagher, Zachary Lewis, Suresh Ambati, et al.
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114776-114776
Open Access | Times Cited: 11
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study
Deepak Garg, Soundappan Kathirvel, Ritesh Agarwal, et al.
Mycoses (2023) Vol. 66, Iss. 9, pp. 787-794
Closed Access | Times Cited: 8
Could cattle dung burning have contributed to the epidemic of COVID‐19‐associated mucormycosis in India? Results of an experimental aero‐mycological study
Soundappan Kathirvel, Valliappan Muthu, Shivaprakash M. Rudramurthy, et al.
Mycoses (2022) Vol. 65, Iss. 11, pp. 1024-1029
Open Access | Times Cited: 11
An old confusion: Entomophthoromycosis versus mucormycosis and their main differences
Jaime David Acosta-España, Kerstin Voigt
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 8
COVID-19, mucormycosis, and the cow: Damned lies!
Valliappan Muthu, Ritesh Agarwal, Arunaloke Chakrabarti
Indian Journal of Medical Microbiology (2023) Vol. 44, pp. 100382-100382
Open Access | Times Cited: 4
SARS-CoV-19-associated Rhino-orbital and cerebral mucormycosis: clinical and radiological presentations
Ashima Mittal, Nitika Mahajan, Devinder Pal Singh Dhanota, et al.
Medical Mycology (2022) Vol. 60, Iss. 9
Open Access | Times Cited: 5
Association of COVID with Mycosis in General
Gurpreet Kaur, Rajinder Kaur, Sumanpreet, et al.
Infectious Disorders - Drug Targets (2024) Vol. 24, Iss. 6
Closed Access
Pathogenesis of COVID-19-Associated Mucormycosis: An Updated Evidence-Based Review
Rimjhim Kanaujia, Priya Sreenivasan, Shivaprakash M. Rudramurthy
Current Fungal Infection Reports (2024) Vol. 18, Iss. 1, pp. 69-75
Closed Access
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research
Russell E. Lewis
Journal of Fungi (2024) Vol. 10, Iss. 6, pp. 382-382
Open Access
Multiple roles for hypoxia inducible factor 1-alpha in airway epithelial cells during mucormycosis
Povilas Kavaliauskas, Yiyou Gu, Naushaba Hasin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Corticosteroids and invasive fungal infections in hospitalized COVID-19 patients – A single-center cross-sectional study
Venkateswaran Ramanathan, Hariswar Pari Thenmozhi, Rakesh Singh, et al.
F1000Research (2024) Vol. 12, pp. 1282-1282
Open Access
Mucormycosis in the COVID-19 scenario beyond hospitalized patients
Alexandro Bonifáz, Andrés Tirado‐Sánchez, Javier Santibáñez, et al.
Future Microbiology (2023) Vol. 18, Iss. 1, pp. 5-8
Closed Access | Times Cited: 1
Re: “COVID-19, mucormycosis, and the cow: Damned lies!”
Jessy Skaria
Indian Journal of Medical Microbiology (2023) Vol. 46, pp. 100462-100462
Open Access | Times Cited: 1
Invasive Sinusitis Presenting with Orbital Complications in COVID Patients: Is Mucor the Only Cause?
Kouser Mohammadi, S. M. Azeem Mohiyuddin, K. C. Prasad, et al.
Indian Journal of Otolaryngology and Head & Neck Surgery (2023) Vol. 76, Iss. 1, pp. 55-63
Closed Access
Corticosteroids and invasive fungal infections in hospitalized COVID-19 patients – A single-center cross-sectional study
Venkateswaran Ramanathan, Hariswar Pari Thenmozhi, Rakesh Singh, et al.
F1000Research (2023) Vol. 12, pp. 1282-1282
Open Access
THE MUCORMYCOSIS CRISIS: AN EPIDEMIC WITHIN A PANDEMIC
A Aamir, Faisal Hanif
Infectious Diseases Journal of Pakistan (2023) Vol. 32, Iss. 4, pp. 159-164
Open Access
Neues aus der Reisemedizin
Unn Klare
Flugmedizin · Tropenmedizin · Reisemedizin - FTR (2022) Vol. 29, Iss. 03, pp. 99-100
Closed Access
Page 1

Scroll to top